Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma
出版年份 2020 全文链接
标题
Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-08-17
DOI
10.1038/s41416-020-1022-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2019) A Vogel et al. ANNALS OF ONCOLOGY
- Low-dose IFN-γ induces tumor cell stemness in the tumor microenvironment of non-small cell lung cancer
- (2019) Mengjia Song et al. CANCER RESEARCH
- Galectin-3 Mediates Tumor Cell–Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling
- (2018) Wei Zhao et al. GASTROENTEROLOGY
- The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment
- (2018) Mohammad Farhad et al. OncoImmunology
- Upregulation of RASSF1A in Colon Cancer by Suppression of Angiogenesis Signaling and Akt Activation
- (2018) Thomas G. Blanchard et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Role of Angiogenesis in Hepatocellular Carcinoma
- (2018) Michael A. Morse et al. CLINICAL CANCER RESEARCH
- Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells
- (2017) Florent Colomb et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiation
- (2017) Mark Kin Fai Ma et al. JOURNAL OF HEPATOLOGY
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
- (2017) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocelluar carcinoma after sorafenib failure: A prospective, open-label, phase II study.
- (2017) T. Yau et al. JOURNAL OF CLINICAL ONCOLOGY
- Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis
- (2016) Kosei Nakajima et al. CANCER RESEARCH
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition
- (2016) Shuai Xiao et al. HEPATOLOGY
- Role of epithelial to mesenchymal transition in hepatocellular carcinoma
- (2016) Gianluigi Giannelli et al. JOURNAL OF HEPATOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway
- (2015) Wei Xu et al. CANCER LETTERS
- Galectin-3 in cancer
- (2014) Lin Song et al. CLINICA CHIMICA ACTA
- Galectin-3 in angiogenesis and metastasis
- (2014) T. Funasaka et al. GLYCOBIOLOGY
- Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription
- (2014) Jaime G Fernández et al. Molecular Cancer
- Nuclear transport of galectin-3 and its therapeutic implications
- (2014) Tatsuyoshi Funasaka et al. SEMINARS IN CANCER BIOLOGY
- Increased Circulation of Galectin-3 in Cancer Induces Secretion of Metastasis-Promoting Cytokines from Blood Vascular Endothelium
- (2013) C. Chen et al. CLINICAL CANCER RESEARCH
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- Galectin-3 Contributes to Melanoma Growth and Metastasis via Regulation of NFAT1 and Autotaxin
- (2012) R. R. Braeuer et al. CANCER RESEARCH
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- Galectin-3 Mediates Nuclear β-Catenin Accumulation and Wnt Signaling in Human Colon Cancer Cells by Regulation of Glycogen Synthase Kinase-3β Activity
- (2009) Shumei Song et al. CANCER RESEARCH
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started